126 related articles for article (PubMed ID: 3510143)
1. Pathogenesis and prevention of the dawn phenomenon in diabetic patients treated with CSII.
Koivisto VA; Yki-Järvinen H; Helve E; Karonen SL; Pelkonen R
Diabetes; 1986 Jan; 35(1):78-82. PubMed ID: 3510143
[TBL] [Abstract][Full Text] [Related]
2. Rarity of a marked "dawn phenomenon" in diabetic subjects treated by continuous subcutaneous insulin infusion.
Bending JJ; Pickup JC; Collins AC; Keen H
Diabetes Care; 1985; 8(1):28-33. PubMed ID: 3971844
[TBL] [Abstract][Full Text] [Related]
3. Improved in vivo insulin effect during continuous subcutaneous insulin infusion in patients with IDDM.
Beck-Nielsen H; Richelsen B; Hasling C; Nielsen OH; Heding L; Sørensen NS
Diabetes; 1984 Sep; 33(9):832-7. PubMed ID: 6381179
[TBL] [Abstract][Full Text] [Related]
4. [Blood sugar control in diabetic patients bearing microinfusors: the importance of the dawn phenomenon].
Consoli A; Capani F; Vitacolonna E; Sensi S
Boll Soc Ital Biol Sper; 1984 Sep; 60(9):1685-9. PubMed ID: 6395872
[TBL] [Abstract][Full Text] [Related]
5. The dawn phenomenon: comparison between normal and insulin-dependent diabetic adolescents.
Arslanian S; Ohki Y; Becker DJ; Drash AL
Pediatr Res; 1992 Mar; 31(3):203-6. PubMed ID: 1313957
[TBL] [Abstract][Full Text] [Related]
6. Strict nocturnal diabetic control diminishes subsequent glycemic escape during acute insulin withdrawal.
Vaughan NJ; Rao RH; Kurtz AB; Buckell HM; Spathis GS
Metabolism; 1986 Feb; 35(2):136-42. PubMed ID: 3511351
[TBL] [Abstract][Full Text] [Related]
7. Continuous subcutaneous insulin infusion fails to correct impaired basal glucose metabolism and impaired insulin sensitivity of adipocytes from patients with type 1 (insulin-dependent) diabetes.
Pedersen O; Hjøllund E; Beck-Nielsen H; Richelsen B; Sørensen NS
Diabetes Res; 1986 Jan; 3(1):17-23. PubMed ID: 3514067
[TBL] [Abstract][Full Text] [Related]
8. Dawn phenomenon in type 1 (insulin-dependent) diabetic adolescents: influence of nocturnal growth hormone secretion.
Beaufrère B; Beylot M; Metz C; Ruitton A; François R; Riou JP; Mornex R
Diabetologia; 1988 Aug; 31(8):607-11. PubMed ID: 3065115
[TBL] [Abstract][Full Text] [Related]
9. Absence of the dawn phenomenon and abnormal lipolysis in type 1 (insulin-dependent) diabetic patients with chronic growth hormone deficiency.
Boyle PJ; Avogaro A; Smith L; Shah SD; Cryer PE; Santiago JV
Diabetologia; 1992 Apr; 35(4):372-9. PubMed ID: 1516766
[TBL] [Abstract][Full Text] [Related]
10. Continuous subcutaneous insulin infusion treatment in insulin-dependent diabetic patients: a comparison with conventional optimized treatment in a long-term study.
Calabrese G; Bueti A; Santeusanio F; Giombolini A; Zega G; Angeletti G; Cartechini MG; Brunetti P
Diabetes Care; 1982; 5(5):457-65. PubMed ID: 7188333
[TBL] [Abstract][Full Text] [Related]
11. Free insulin levels and metabolic effects of meal-time bolus and square-wave intraperitoneal insulin infusion in insulin-dependent diabetic patients.
Jimenez JT; Walford S; Home PD; Hanning I; Alberti KG
Diabetologia; 1985 Oct; 28(10):728-33. PubMed ID: 3905470
[TBL] [Abstract][Full Text] [Related]
12. Continuous subcutaneous insulin infusion therapy decreases insulin resistance in type 1 diabetes.
Yki-Järvinen H; Koivisto VA
J Clin Endocrinol Metab; 1984 Apr; 58(4):659-66. PubMed ID: 6365945
[TBL] [Abstract][Full Text] [Related]
13. Sandostatin, a new analogue of somatostatin, reduces the metabolic changes induced by the nocturnal interruption of continuous subcutaneous insulin infusion in type 1 (insulin-dependent) diabetic patients.
Scheen AJ; Gillet J; Rosenthaler J; Guiot J; Henrivaux P; Jandrain B; Lefèbvre PJ
Diabetologia; 1989 Nov; 32(11):801-9. PubMed ID: 2687064
[TBL] [Abstract][Full Text] [Related]
14. Nocturnal spikes of growth hormone secretion cause the dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus by decreasing hepatic (and extrahepatic) sensitivity to insulin in the absence of insulin waning.
Perriello G; De Feo P; Torlone E; Fanelli C; Santeusanio F; Brunetti P; Bolli GB
Diabetologia; 1990 Jan; 33(1):52-9. PubMed ID: 2406181
[TBL] [Abstract][Full Text] [Related]
15. Insulin-mediated glucose disposal in type 1 (insulin-dependent) diabetic subjects treated by continuous subcutaneous or intraperitoneal insulin fusion.
Beylot M; Khalfallah Y; Laville M; Sautot G; Dechaud H; Serusclat P; Berthezene F; Riou JP; Mornex R
Diabete Metab; 1987; 13(4):450-6. PubMed ID: 3315766
[TBL] [Abstract][Full Text] [Related]
16. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
Saccà L; Sherwin R; Hendler R; Felig P
J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832
[TBL] [Abstract][Full Text] [Related]
17. Effect of prolonged hyperglycemia on growth hormone levels and insulin sensitivity in insulin-dependent diabetes mellitus.
Fowelin J; Attvall S; von Schenck H; Bengtsson BA; Smith U; Lager I
Metabolism; 1993 Mar; 42(3):387-94. PubMed ID: 8487660
[TBL] [Abstract][Full Text] [Related]
18. Sequence of events during development of the dawn phenomenon in insulin-dependent diabetes mellitus.
Campbell PJ; Bolli GB; Cryer PE; Gerich JE
Metabolism; 1985 Dec; 34(12):1100-4. PubMed ID: 3906350
[TBL] [Abstract][Full Text] [Related]
19. Metabolic alterations after a two-hour nocturnal interruption of a continuous subcutaneous insulin infusion.
Scheen A; Castillo M; Jandrain B; Krzentowski G; Henrivaux P; Luyckx AS; Lefèbvre PJ
Diabetes Care; 1984; 7(4):338-42. PubMed ID: 6381007
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of hyperglycemia-induced insulin resistance in whole body and skeletal muscle of type I diabetic patients.
Vuorinen-Markkola H; Koivisto VA; Yki-Jarvinen H
Diabetes; 1992 May; 41(5):571-80. PubMed ID: 1568526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
